Search
View Show Page
JACC Specialty Journals
JACC Asia - Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4): A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
Aug 15, 2023
6:58
Save
Follow
Share
Science
Episode Description
Commentary by Dr Jian-Jun Li
Listen On
How to rate & review on Apple Podcasts
Proudly Supported by
Patrons of Health Podcast Library
Supporting Shows